(Q42233425)

19 October 2017

Combination sequential chemotherapy in advanced reticulum cell sarcoma (English)

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

2 February 2023

1 reference

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

2 February 2023

author name string

M. Levitt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4551303

2 February 2023

J. C. Marsh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4551303

2 February 2023

R. C. DeConti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4551303

2 February 2023

M. S. Mitchell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4551303

2 February 2023

R. T. Skeel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4551303

2 February 2023

L. R. Farber

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4551303

2 February 2023

J. R. Bertino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4551303

2 February 2023

language of work or name

English

0 references

publication date

1 March 1972

1 reference

full work available at URL

19 October 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

2 February 2023

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

2 February 2023

1 reference

19 October 2017

29

1 reference

19 October 2017

630-636

1 reference

19 October 2017

3

1 reference

A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS.

19 October 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197203%2929%3A3%3C630%3A%3AAID-CNCR2820290316%3E3.0.CO%3B2-Q

High-dose corticoid therapy in Hodgkin's disease and other lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197203%2929%3A3%3C630%3A%3AAID-CNCR2820290316%3E3.0.CO%3B2-Q

21 January 2018

2

28

811

Carbone

1968

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

Combination chemotherapy in the management of breast cancer metastases.

2 February 2023

4

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

2 February 2023

6

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia

2 February 2023

8

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

Eradication Of Leukaemic Cells (L1210) by Methotrexate and Methotrexate Plus Citrovorum Factor

2 February 2023

9

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

2 February 2023

12

29

2272

Henderson

1970

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

2 February 2023

Molecular Pharmacology

15

5

557

Hryniuk

1969

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

Efficacy of cyclophosphamide in the management of reticulum cell sarcoma

2 February 2023

16

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

Corticosteroids in the treatment of the reticuloses

2 February 2023

18

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

2 February 2023

19

26

1090

Karnofsky

1966

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

BCNU (1,3), BIS(B-chloroethyl)-1-nitrosourea. Effects on advanced Hodgkin's disease and other neoplasia

2 February 2023

21

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma

2 February 2023

22

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

2 February 2023

24

30

1425

Reitemeier

1970

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

Biochemical, biological, pharmacologic, toxicologic, kinetic and clinical (subhuman and human) relationships

2 February 2023

25

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

clinical experience with procarbazine in Hodgkin's disease, reticulum cell sarcoma, and lymphosarcoma

2 February 2023

27

1 reference

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(197203)29:3%3C630::AID-CNCR2820290316%3E3.0.CO;2-Q

2 February 2023

Identifiers

10.1002/1097-0142(197203)29:3<630::AID-CNCR2820290316>3.0.CO;2-Q

1 reference

19 October 2017

1 reference